GILEAD SCIENCES, INC. - 31 Dec 2024 SCHEDULE 13G/A Report for Ikena Oncology, Inc. Common Stock (IKNA)

Filing Manager: GILEAD SCIENCES, INC.
Reporting Manager: GILEAD SCIENCES INC
Security: Ikena Oncology, Inc. Common Stock
Symbol: IKNA
Shares outstanding: 42,258,667 shares
Disclosed Ownership: 1,521,312 shares
Ownership: 3.6%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 16:22:08 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GILEAD SCIENCES INC	3.6%	1,521,312	1,521,312	0	/s/ Andrew Dickinson	Andrew Dickinson, Chief Financial Officer